Works matching DE "MULTIPLE sclerosis treatment"


Results: 3323
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Use of non-specific intravenous human immunoglobulins in Spanish hospitals; need for a hospital protocol.

    Published in:
    European Journal of Clinical Pharmacology, 2010, v. 66, n. 6, p. 633, doi. 10.1007/s00228-010-0800-y
    By:
    • Ruiz-Antorán, Belen;
    • Agustí Escasany, Antònia;
    • Vallano Ferraz, Antoni;
    • Danés Carreras, Imma;
    • Riba, Neus;
    • Mateu Escudero, Silvia;
    • Costa, Joan;
    • Sánchez Santiago, Mª;
    • Laredo, Leonor;
    • Durán Quintana, José;
    • Castillo, Juan;
    • Abad-Santos, Francisco;
    • Payares Herrera, Concepción;
    • Sádaba Díaz de Rada, Belén;
    • Gómez Ontañón, Eugenio
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19

    Old drug, new price?

    Published in:
    Nature Reviews Immunology, 2012, v. 12, n. 12, p. 810, doi. 10.1038/nri3348
    By:
    • Bordon, Yvonne
    Publication type:
    Article
    20
    21
    22

    Multiple Skleroz ve Tamamlayıcı Terapiler.

    Published in:
    Journal of Academic Research in Nursing (JAREN), 2019, v. 5, n. 3, p. 228, doi. 10.5222/jaren.2019.17363
    By:
    • ÖZDELİKARA, Afitap;
    • TAŞTAN, Ahsen
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients.

    Published in:
    Annals of Clinical & Translational Neurology, 2019, v. 6, n. 2, p. 355, doi. 10.1002/acn3.711
    By:
    • Medina, Silvia;
    • Sainz de la Maza, Susana;
    • Villarrubia, Noelia;
    • Álvarez‐Lafuente, Roberto;
    • Costa‐Frossard, Lucienne;
    • Arroyo, Rafael;
    • Monreal, Enric;
    • Tejeda‐Velarde, Amalia;
    • Rodríguez‐Martín, Eulalia;
    • Roldán, Ernesto;
    • Álvarez‐Cermeño, José C.;
    • Villar, Luisa M.
    Publication type:
    Article
    37
    38
    39

    Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study.

    Published in:
    Annals of Clinical & Translational Neurology, 2018, v. 5, n. 3, p. 346, doi. 10.1002/acn3.534
    By:
    • Miller, David H.;
    • Lublin, Fred D.;
    • Sormani, Maria Pia;
    • Kappos, Ludwig;
    • Yaldizli, Özgür;
    • Freedman, Mark S.;
    • Cree, Bruce A. C.;
    • Weiner, Howard L.;
    • Lubetzki, Catherine;
    • Hartung, Hans‐Peter;
    • Montalban, Xavier;
    • Uitdehaag, Bernard M. J.;
    • MacManus, David G.;
    • Yousry, Tarek A.;
    • Gandini Wheeler‐Kingshott, Claudia A. M.;
    • Li, Bingbing;
    • Putzki, Norman;
    • Merschhemke, Martin;
    • Häring, Dieter A.;
    • Wolinsky, Jerry S.
    Publication type:
    Article
    40

    Infectious risk stratification in multiple sclerosis patients receiving immunotherapy.

    Published in:
    Annals of Clinical & Translational Neurology, 2017, v. 4, n. 12, p. 909, doi. 10.1002/acn3.491
    By:
    • Graf, Jonas;
    • Leussink, Verena I.;
    • Dehmel, Thomas;
    • Ringelstein, Marius;
    • Goebels, Norbert;
    • Adams, Ortwin;
    • MacKenzie, Colin R.;
    • Warnke, Clemens;
    • Feldt, Torsten;
    • Lammerskitten, Anna;
    • Klotz, Luisa;
    • Meuth, Sven;
    • Wiendl, Heinz;
    • Hartung, Hans‐Peter;
    • Aktas, Orhan;
    • Albrecht, Philipp
    Publication type:
    Article
    41
    42
    43
    44
    45
    46

    Quantified CSF antibody reactivity against myelin in multiple sclerosis.

    Published in:
    Annals of Clinical & Translational Neurology, 2015, v. 2, n. 12, p. 1116, doi. 10.1002/acn3.264
    By:
    • Sun, Xingwen;
    • Bakhti, Mostafa;
    • Fitzner, Dirk;
    • Schnaars, Mareike;
    • Kruse, Niels;
    • Coskun, Ünal;
    • Kremser, Christiane;
    • Willecke, Klaus;
    • Kappos, Ludwig;
    • Kuhle, Jens;
    • Simons, Mikael
    Publication type:
    Article
    47

    Comparative efficacy of switching to natalizumab in active multiple sclerosis.

    Published in:
    Annals of Clinical & Translational Neurology, 2015, v. 2, n. 4, p. 373, doi. 10.1002/acn3.180
    By:
    • Spelman, Timothy;
    • Kalincik, Tomas;
    • Zhang, Annie;
    • Pellegrini, Fabio;
    • Wiendl, Heinz;
    • Kappos, Ludwig;
    • Tsvetkova, Larisa;
    • Belachew, Shibeshih;
    • Hyde, Robert;
    • Verheul, Freek;
    • Grand‐Maison, Francois;
    • Izquierdo, Guillermo;
    • Grammond, Pierre;
    • Duquette, Pierre;
    • Lugaresi, Alessandra;
    • Lechner‐Scott, Jeannette;
    • Oreja‐Guevara, Celia;
    • Hupperts, Raymond;
    • Petersen, Thor;
    • Barnett, Michael
    Publication type:
    Article
    48
    49

    Fingolimod treatment promotes regulatory phenotype and function of B cells.

    Published in:
    Annals of Clinical & Translational Neurology, 2015, v. 2, n. 2, p. 119, doi. 10.1002/acn3.155
    By:
    • Grützke, Berit;
    • Hucke, Stephanie;
    • Gross, Catharina C.;
    • Herold, Martin V. B.;
    • Posevitz‐Fejfar, Anita;
    • Wildemann, Brigitte T.;
    • Kieseier, Bernd C.;
    • Dehmel, Thomas;
    • Wiendl, Heinz;
    • Klotz, Luisa
    Publication type:
    Article
    50